GLP-1 drugs such as semaglutide are reshaping treatment of obesity, diabetes and cardiovascular disease with broader physiological effects now emerging
Book a consultation with MINT Stl to discover your options for weight loss injections
WARNING: Risk of Thyroid C-Cell Tumors In animal studies, GLP-1 receptor agonists have been associated with thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)
The efficacy of Semaglutide GLP-1 has shown its potential and has become a treatment for obesity and non-alcoholic fatty liver disease
Ferritin nanoparticle-based SpyTag/SpyCatcher-enabled click vaccine for tumor immunotherapy
Chronic Weight Management A higher-dose version of semaglutide is approved for weight management in adults who have a body mass index (BMI) of 30 or higher , or 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, or high cholesterol